Related Experiment Video
Updated: Aug 17, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Influence of prolonged corticosteroid therapy on the outcome of steroid-responsive nephrotic syndrome
H Matsukura1, S Inaba, K Shinozaki
1Department of Pediatrics, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-0194, Japan. matsukur@ms.toyama-mpu.ac.jp
Insights
Long-term corticosteroid use for childhood nephrotic syndrome may stunt adult height. However, cyclophosphamide treatment appears to preserve adult fertility.
Area of Science:
- Pediatric Nephrology
- Endocrinology
- Reproductive Health
Background:
- Steroid-responsive nephrotic syndrome (SRNS) is a common childhood kidney disease.
- Long-term management often involves corticosteroids, raising concerns about growth and fertility.
- The impact of sustained corticosteroid therapy versus intermittent treatment on adult outcomes requires further investigation.
Purpose of the Study:
- To evaluate the long-term effects of corticosteroid therapy on adult height in patients with childhood SRNS.
- To assess the fertility outcomes in adult patients previously treated for SRNS.
- To compare outcomes between patients in sustained remission off corticosteroids and those requiring ongoing steroid therapy.
Main Methods:
- Retrospective study of 86 adult patients (20-40 years) with childhood-diagnosed SRNS.
- Analysis of treatment history, including corticosteroid duration and cyclophosphamide use.
- Assessment of final adult height (standard deviation score) and self-reported fertility (marriage, children).
Main Results:
- Mean final height was comparable between males and females.
- Patients requiring continuous corticosteroids for remission had significantly shorter final heights than those in remission off steroids (p < 0.005).
- Ten cyclophosphamide-treated patients married, and nine had healthy children, suggesting preserved fertility.
Conclusions:
- Sustained corticosteroid therapy for SRNS in childhood may be associated with reduced adult height.
- A 12-week course of cyclophosphamide appears to be linked with normal adult fertility.
- Long-term monitoring of growth and reproductive health is crucial for SRNS survivors.
Abstract:
Eighty-six patients (59 males and 27 females) diagnosed with steroid-responsive nephrotic syndrome during childhood were identified. The patients were 20-40 years of age (mean 27.0 +/- 5.0) with a mean follow-up period of 19.5 +/- 5.9 years. All patients had been treated with a long-term tapering corticosteroid therapy. Thirty patients had also received a course of cyclophosphamide (2 mg/kg/day for 12 weeks). Sixty-six had achieved sustained remission off corticosteroids, while 20 were still receiving corticosteroids to maintain remission. None of the 86 patients had proteinuria or renal insufficiency at the time of the study. Mean final heights in males and females were similar (-0.51 +/- 1.21 and -0.23 +/- 1.16 standard deviation score). Mean final height of 20 steroid-dependent patients was significantly less than that of 66 in remission off corticosteroids (p < 0.005). Ten cyclophosphamide-treated patients got married and 9 had at least 1 healthy child. In children with steroid-responsive nephrotic syndrome, the need for corticosteroid therapy to maintain remission may be associated with decreased adult height. Patients who received a 12-week course of cyclophosphamide are likely to be normally fertile as adults.
More Related Videos
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
05:18Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Cushing Syndrome I: Introduction
Cushing Syndrome II: Pathophysiology